Copyright Reports & Markets. All rights reserved.

Global EPA/DHA Omega-3 Market Insights, Forecast to 2025

Buy now

Table of Contents

    1 Study Coverage

    • 1.1 EPA/DHA Omega-3 Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global EPA/DHA Omega-3 Market Size Growth Rate by Product
      • 1.4.2 Capsule
      • 1.4.3 Powder
    • 1.5 Market by End User
      • 1.5.1 Global EPA/DHA Omega-3 Market Size Growth Rate by End User
      • 1.5.2 Infant Formula
      • 1.5.3 Fortified Foods and Beverages
      • 1.5.4 Nutritional Supplements
      • 1.5.5 Pharmaceuticals
      • 1.5.6 Clinical Nutrition
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global EPA/DHA Omega-3 Market Size
      • 2.1.1 Global EPA/DHA Omega-3 Revenue 2014-2025
      • 2.1.2 Global EPA/DHA Omega-3 Sales 2014-2025
    • 2.2 EPA/DHA Omega-3 Growth Rate by Regions
      • 2.2.1 Global EPA/DHA Omega-3 Sales by Regions
      • 2.2.2 Global EPA/DHA Omega-3 Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 EPA/DHA Omega-3 Sales by Manufacturers
      • 3.1.1 EPA/DHA Omega-3 Sales by Manufacturers
      • 3.1.2 EPA/DHA Omega-3 Sales Market Share by Manufacturers
      • 3.1.3 Global EPA/DHA Omega-3 Market Concentration Ratio (CR5 and HHI)
    • 3.2 EPA/DHA Omega-3 Revenue by Manufacturers
      • 3.2.1 EPA/DHA Omega-3 Revenue by Manufacturers (2014-2019)
      • 3.2.2 EPA/DHA Omega-3 Revenue Share by Manufacturers (2014-2019)
    • 3.3 EPA/DHA Omega-3 Price by Manufacturers
    • 3.4 EPA/DHA Omega-3 Manufacturing Base Distribution, Product Types
      • 3.4.1 EPA/DHA Omega-3 Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers EPA/DHA Omega-3 Product Type
      • 3.4.3 Date of International Manufacturers Enter into EPA/DHA Omega-3 Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global EPA/DHA Omega-3 Sales by Product
    • 4.2 Global EPA/DHA Omega-3 Revenue by Product
    • 4.3 EPA/DHA Omega-3 Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global EPA/DHA Omega-3 Breakdown Data by End User

    6 North America

    • 6.1 North America EPA/DHA Omega-3 by Countries
      • 6.1.1 North America EPA/DHA Omega-3 Sales by Countries
      • 6.1.2 North America EPA/DHA Omega-3 Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America EPA/DHA Omega-3 by Product
    • 6.3 North America EPA/DHA Omega-3 by End User

    7 Europe

    • 7.1 Europe EPA/DHA Omega-3 by Countries
      • 7.1.1 Europe EPA/DHA Omega-3 Sales by Countries
      • 7.1.2 Europe EPA/DHA Omega-3 Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe EPA/DHA Omega-3 by Product
    • 7.3 Europe EPA/DHA Omega-3 by End User

    8 Asia Pacific

    • 8.1 Asia Pacific EPA/DHA Omega-3 by Countries
      • 8.1.1 Asia Pacific EPA/DHA Omega-3 Sales by Countries
      • 8.1.2 Asia Pacific EPA/DHA Omega-3 Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific EPA/DHA Omega-3 by Product
    • 8.3 Asia Pacific EPA/DHA Omega-3 by End User

    9 Central & South America

    • 9.1 Central & South America EPA/DHA Omega-3 by Countries
      • 9.1.1 Central & South America EPA/DHA Omega-3 Sales by Countries
      • 9.1.2 Central & South America EPA/DHA Omega-3 Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America EPA/DHA Omega-3 by Product
    • 9.3 Central & South America EPA/DHA Omega-3 by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa EPA/DHA Omega-3 by Countries
      • 10.1.1 Middle East and Africa EPA/DHA Omega-3 Sales by Countries
      • 10.1.2 Middle East and Africa EPA/DHA Omega-3 Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa EPA/DHA Omega-3 by Product
    • 10.3 Middle East and Africa EPA/DHA Omega-3 by End User

    11 Company Profiles

    • 11.1 WHC
      • 11.1.1 WHC Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 WHC EPA/DHA Omega-3 Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 WHC EPA/DHA Omega-3 Products Offered
      • 11.1.5 WHC Recent Development
    • 11.2 Viva
      • 11.2.1 Viva Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Viva EPA/DHA Omega-3 Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Viva EPA/DHA Omega-3 Products Offered
      • 11.2.5 Viva Recent Development
    • 11.3 OmegaVia
      • 11.3.1 OmegaVia Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 OmegaVia EPA/DHA Omega-3 Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 OmegaVia EPA/DHA Omega-3 Products Offered
      • 11.3.5 OmegaVia Recent Development
    • 11.4 WHC
      • 11.4.1 WHC Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 WHC EPA/DHA Omega-3 Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 WHC EPA/DHA Omega-3 Products Offered
      • 11.4.5 WHC Recent Development
    • 11.5 Nutrigold
      • 11.5.1 Nutrigold Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Nutrigold EPA/DHA Omega-3 Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Nutrigold EPA/DHA Omega-3 Products Offered
      • 11.5.5 Nutrigold Recent Development
    • 11.6 Omax3
      • 11.6.1 Omax3 Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Omax3 EPA/DHA Omega-3 Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Omax3 EPA/DHA Omega-3 Products Offered
      • 11.6.5 Omax3 Recent Development
    • 11.7 The
      • 11.7.1 The Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 The EPA/DHA Omega-3 Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 The EPA/DHA Omega-3 Products Offered
      • 11.7.5 The Recent Development
    • 11.8 Ocean
      • 11.8.1 Ocean Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Ocean EPA/DHA Omega-3 Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Ocean EPA/DHA Omega-3 Products Offered
      • 11.8.5 Ocean Recent Development
    • 11.9 InnovixLabs
      • 11.9.1 InnovixLabs Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 InnovixLabs EPA/DHA Omega-3 Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 InnovixLabs EPA/DHA Omega-3 Products Offered
      • 11.9.5 InnovixLabs Recent Development
    • 11.10 Controlled
      • 11.10.1 Controlled Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Controlled EPA/DHA Omega-3 Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Controlled EPA/DHA Omega-3 Products Offered
      • 11.10.5 Controlled Recent Development

    12 Future Forecast

    • 12.1 EPA/DHA Omega-3 Market Forecast by Regions
      • 12.1.1 Global EPA/DHA Omega-3 Sales Forecast by Regions 2019-2025
      • 12.1.2 Global EPA/DHA Omega-3 Revenue Forecast by Regions 2019-2025
    • 12.2 EPA/DHA Omega-3 Market Forecast by Product
      • 12.2.1 Global EPA/DHA Omega-3 Sales Forecast by Product 2019-2025
      • 12.2.2 Global EPA/DHA Omega-3 Revenue Forecast by Product 2019-2025
    • 12.3 EPA/DHA Omega-3 Market Forecast by End User
    • 12.4 North America EPA/DHA Omega-3 Forecast
    • 12.5 Europe EPA/DHA Omega-3 Forecast
    • 12.6 Asia Pacific EPA/DHA Omega-3 Forecast
    • 12.7 Central & South America EPA/DHA Omega-3 Forecast
    • 12.8 Middle East and Africa EPA/DHA Omega-3 Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 EPA/DHA Omega-3 Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global EPA/DHA Omega-3 market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the EPA/DHA Omega-3 market based on company, product type, end user and key regions.

      This report studies the global market size of EPA/DHA Omega-3 in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of EPA/DHA Omega-3 in these regions.
      This research report categorizes the global EPA/DHA Omega-3 market by top players/brands, region, type and end user. This report also studies the global EPA/DHA Omega-3 market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      WHC
      Viva
      OmegaVia
      WHC
      Nutrigold
      Omax3
      The
      Ocean
      InnovixLabs
      Controlled

      Market size by Product
      Capsule
      Powder
      Market size by End User
      Infant Formula
      Fortified Foods and Beverages
      Nutritional Supplements
      Pharmaceuticals
      Clinical Nutrition

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global EPA/DHA Omega-3 market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of EPA/DHA Omega-3 market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global EPA/DHA Omega-3 companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of EPA/DHA Omega-3 submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of EPA/DHA Omega-3 are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of EPA/DHA Omega-3 market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now